The mechanisms underlying the inhibition of lymphocyte proliferative response by rabbit blastocoelic fluid collected on day 12 of embryonic development were investigated. (Kolb et al, 1984), cytotoxic cells (Chaouat and Kolb, 1985) and macrophages (Lu et al, 1984). The inhibition of the proliferat¬ ive response to lectins, such as phytohaemagglutinin (PHA) and concanavalin A, by soluble immunosuppressive factors obtained from embryo culture supernatant has also been documented (Kolb et al, 1984; Chaouat and Kolb, 1985; Daya and Clark, 1986a,b; Watson, 1990 
Introduction
Implantation of embryos in certain mammals, such as humans and rabbits, involves cell fusion between the embryo and the uterine endometrial cells, which favours embryo-uterine exchanges (Schlafke and Enders, 1975; Morin el al, 1992) . A significant accumulation of leukocytes in the newly formed decidua has been demonstrated (Clark et al, 1984) in some animals (including rats, mice and humans; see Stewart, 1991 , for a review), leading to close contact between the embryonic trophoblast and the maternal immune system. Thus, despite the fact that trophoblastic MHC class I antigens are apparently not in direct contact with maternal blood (Redman et al, 1984; Hunt et al, 1988) , embryos are exposed to maternal immune cells in the decidua, such as natural killer (NK)-like cells (Croy et al, 1985; Gambel et al, 1985) , which have been associated with spontaneous abortions in mice (de Fougerolles and Baines, 1987; Gendron and Baines, 1988; Zheng et al, 1993) . Even (Drake and Head, 1989;  King and Loke, 1990) . Because the uterus is, therefore, a potentially hostile environment for the embryo, immunological rejection could be expected.
It is our hypothesis that, to avoid such a disastrous fate, the embryo must locally regulate the maternal immune system. This could be accomplished in several ways: local accumulation of suppressor cells (Clark et al, 1984) , an absence of major histocompatibility complex (MHC) class II antigens (Redman et al, 1984; Ellis et al, 1986) , the presence of truncated MHC class I antigen on trophoblast cells (Ellis et al, 1990) , and local production of immunoregulatory factors, such as the ovine trophoblast protein-1 (OTP-1) (Newton et al, 1989; Niwano et al, 1989; Fillion et al, 1991) . A local rather than a systemic immunosuppression has been demonstrated (Chaouat and Monnot, 1984; Pandian el al, 1988; Lambert et al, 1989a) .
Suppressive activity affects the functional activities of NK cells (Kolb et al, 1984) , cytotoxic cells (Chaouat and Kolb, 1985) and macrophages (Lu et al, 1984) . The inhibition of the proliferat¬ ive response to lectins, such as phytohaemagglutinin (PHA) and concanavalin A, by soluble immunosuppressive factors obtained from embryo culture supernatant has also been documented (Kolb et al, 1984; Chaouat and Kolb, 1985; Daya and Clark, 1986a,b; Watson, 1990 that interaction between IL-2 and its receptor is necessary for the progression of activated T-cells through the cell cycle and their subsequent proliferation (Cantrell and Smith, 1984) .
Day-12 blastocoelic fluid treatment prevents IL-2Ra membrane expression on lymphocytes (Fig. 2a) , which may reflect the quiescent state of concanavalin A/day-12 blastocoelic fluidtreated cells observed in Fig. I (Cantrell and Smith, 1984) that lymphocyte proliferation peaks when a maximum of cell surface IL-2R expression is attained, which is 72 h after lectin activation (Leonard et al, 1985; Smith, 1988 (Fig. 5 a) , day-12 blastocoelic fluid did not completely abolish cell proliferation (Fig. 5b) (Fig. 7) . (Leonard et al, 1985) , closely parallels [3H]thymidine uptake (Cantrell and Smith, 1984) , and peaks at 72 h after lectin activation (Leonard et al, 1985; Smith, 1988) (Croy et al, 1985; Gambel et al, 1985) and seem to be implicated in spontaneous abortions (de Fougerolles and Baines, 1987; Gendron and Baines, 1988) . Granulated metrial gland cells, found in rodents (Croy, 1990) , and large granulated lymphocytes, found in humans (King and Loke, 1991) , are present in early decidua, both of which are related morphologically, phenotypically and functionally to NK cells (Croy, 1990; King and Loke, 1990; Lin et al, 1991 (Yoshimura et al, 1991) and pregnancy zone protein (Saito et al, 1990) inhibit IL-2 production without interfering with IL-2R membrane expression. Nicholas and Payani (1985) showed that retroplacental serum suppresses mixed lymphocyte reaction through an inhibition of IL-2 production. Yoshida et al (1990) (1989) reported the inhibitory effects of a human factor released from the placental chorionic membrane that prevents the expression of IL-2R. In addition, hydatidiform mole extracts are known to suppress IL-2-induced proliferation of T-cells (Bennett et al, 1990 Clark, 1982) which, at a certain stage in pregnancy, are thought to replace the protective role of embryo-fetal immuno¬ suppressive factor(s) (Lambert et al, 1989a) . We propose that the active molecule(s) present in day-12 blastocoelic fluid, which does not act by cytotoxic means as the effect is com¬ pletely reversible (Pandian et al, 1988) , could participate in the survival of the fetal semi-allograft by preventing transcription of genes encoding IL-2 and IL-2R. Such a mechanism could thus prevent the accidental activation of lymphocytes located in the decidua that are potentially harmful to the fetus.
